• Study on the Effectiveness and Safety of Olorofim vs. Liposomal Amphotericin B for Patients with Invasive Aspergillosis

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Belgium France Germany Italy The Netherlands Spain
  • Study Comparing Talquetamab, Daratumumab, and Pomalidomide with Drug Combination for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Belgium Czechia France Germany Greece Italy +3
  • Study on the Safety and Effects of Dasatinib for Reducing Inflammation in People with HIV on Antiretroviral Therapy

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Spain
  • Study Comparing Doxycycline and Benzathine Benzylpenicillin for Treating Early Syphilis in Adults

    Not recruiting

    3 1 1 1
    Investigated diseases:
    France
  • Study on Vimseltinib for Patients with Tenosynovial Giant Cell Tumor

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy The Netherlands Norway Poland +1
  • Study on the Effectiveness and Safety of Iptacopan for Adults with Atypical Hemolytic Uremic Syndrome Not Previously Treated with Complement Inhibitors

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Czechia Greece Slovakia Slovenia
  • Study Comparing Tacrolimus Levels in Children with Organ Transplants Switching from Prograf to Advagraf

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Czechia
  • A Phase 1/2a Study of BNT142 Safety and Early Effectiveness in Patients with Advanced Solid Tumors Expressing CLDN6 Protein

    Not recruiting

    2 1 1
    Germany The Netherlands Spain
  • Study on Aspirin’s Effect on Recurrence and Survival in Patients with Non-Metastatic Breast, Colon, Rectal, Stomach, Esophageal, and Prostate Cancer

    Not recruiting

    3 1 1
    Investigated drugs:
    Ireland
  • Study of Venetoclax and Low Dose Cytarabine for Untreated Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France

powered by